BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 11051237)

  • 1. P73 gene expression in ovarian cancer tissues and cell lines.
    Chen CL; Ip SM; Cheng D; Wong LC; Ngan HY
    Clin Cancer Res; 2000 Oct; 6(10):3910-5. PubMed ID: 11051237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic and genetic alterations of p33ING1b in ovarian cancer.
    Shen DH; Chan KY; Khoo US; Ngan HY; Xue WC; Chiu PM; Ip P; Cheung AN
    Carcinogenesis; 2005 Apr; 26(4):855-63. PubMed ID: 15677627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression and promotor methylation of p73 gene in ovarian epithelial tumors].
    Zhang YL; Guo XR; Shen DH; Cheng YX; Liang XD; Chen YX; Wang Y
    Zhonghua Bing Li Xue Za Zhi; 2012 Jan; 41(1):33-8. PubMed ID: 22455848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
    Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC
    Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of p73 in human borderline and invasive ovarian tumor.
    Ng SW; Yiu GK; Liu Y; Huang LW; Palnati M; Jun SH; Berkowitz RS; Mok SC
    Oncogene; 2000 Apr; 19(15):1885-90. PubMed ID: 10773878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical relevance of dominant-negative p73 isoforms for responsiveness to chemotherapy and survival in ovarian cancer: evidence for a crucial p53-p73 cross-talk in vivo.
    Concin N; Hofstetter G; Berger A; Gehmacher A; Reimer D; Watrowski R; Tong D; Schuster E; Hefler L; Heim K; Mueller-Holzner E; Marth C; Moll UM; Zeimet AG; Zeillinger R
    Clin Cancer Res; 2005 Dec; 11(23):8372-83. PubMed ID: 16322298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of p73 splice variants and protein in benign and malignant ovarian tumours.
    Zwahlen D; Tschan MP; Grob TJ; Peters UR; Fink D; Haenggi W; Altermatt HJ; Cajot JF; Tobler A; Fey MF; Aebi S
    Int J Cancer; 2000 Oct; 88(1):66-70. PubMed ID: 10962441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated and biallelic expression of p73 is associated withprogression of human bladder cancer.
    Chi SG; Chang SG; Lee SJ; Lee CH; Kim JI; Park JH
    Cancer Res; 1999 Jun; 59(12):2791-3. PubMed ID: 10383132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent inactivation of the p73 gene by abnormal methylation or LOH in non-Hodgkin's lymphomas.
    Martinez-Delgado B; Melendez B; Cuadros M; Jose Garcia M; Nomdedeu J; Rivas C; Fernandez-Piqueras J; Benítez J
    Int J Cancer; 2002 Nov; 102(1):15-9. PubMed ID: 12353228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of the wild type p73 gene in human bladder cancer.
    Yokomizo A; Mai M; Tindall DJ; Cheng L; Bostwick DG; Naito S; Smith DI; Liu W
    Oncogene; 1999 Feb; 18(8):1629-33. PubMed ID: 10102633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent loss of heterozygosity at 1p36 in ovarian adenocarcinomas but the gene encoding p73 is unlikely to be the target.
    Imyanitov EN; Birrell GW; Filippovich I; Sorokina N; Arnold J; Mould MA; Wright K; Walsh M; Mok SC; Lavin MF; Chenevix-Trench G; Khanna KK
    Oncogene; 1999 Aug; 18(32):4640-2. PubMed ID: 10467409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt's lymphoma is associated with 5' CpG island methylation.
    Corn PG; Kuerbitz SJ; van Noesel MM; Esteller M; Compitello N; Baylin SB; Herman JG
    Cancer Res; 1999 Jul; 59(14):3352-6. PubMed ID: 10416592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of p73 expression in six non-small cell lung cancer cell lines is associated with 5'CpG island methylation.
    Liu K; Zhan M; Zheng P
    Exp Mol Pathol; 2008 Feb; 84(1):59-63. PubMed ID: 18022156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent allelic losses on the short arm of chromosome 1 and decreased expression of the p73 gene at 1p36.3 in squamous cell carcinoma of the oral cavity.
    Araki D; Uzawa K; Watanabe T; Shiiba M; Miyakawa A; Yokoe H; Tanzawa H
    Int J Oncol; 2002 Feb; 20(2):355-60. PubMed ID: 11788901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of the wild type p73 gene in breast cancer tissues and cell lines.
    Zaika AI; Kovalev S; Marchenko ND; Moll UM
    Cancer Res; 1999 Jul; 59(13):3257-63. PubMed ID: 10397274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression but lack of mutation and methylation of p73 in hepatocellular carcinoma.
    Pan H; Liao SJ; Lai WY; Lu HC; Hsiao KM
    Acta Oncol; 2002; 41(6):550-5. PubMed ID: 12546528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allelic expression of the putative tumor suppressor gene p73 in human fetal tissues and tumor specimens.
    Hu JF; Ulaner GA; Oruganti H; Ivaturi RD; Balagura KA; Pham J; Vu TH; Hoffman AR
    Biochim Biophys Acta; 2000 Apr; 1491(1-3):49-56. PubMed ID: 10760569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of imprinting and elevated expression of wild-type p73 in human gastric adenocarcinoma.
    Kang MJ; Park BJ; Byun DS; Park JI; Kim HJ; Park JH; Chi SG
    Clin Cancer Res; 2000 May; 6(5):1767-71. PubMed ID: 10815895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RPS6KA2, a putative tumour suppressor gene at 6q27 in sporadic epithelial ovarian cancer.
    Bignone PA; Lee KY; Liu Y; Emilion G; Finch J; Soosay AE; Charnock FM; Beck S; Dunham I; Mungall AJ; Ganesan TS
    Oncogene; 2007 Feb; 26(5):683-700. PubMed ID: 16878154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wilms tumor gene protein 1 is associated with ovarian cancer metastasis and modulates cell invasion.
    Barbolina MV; Adley BP; Shea LD; Stack MS
    Cancer; 2008 Apr; 112(7):1632-41. PubMed ID: 18260155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.